...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Bear

im tired of all the PM's & conversations people have had with our dear Donny. Enough is enough! He's pulling in big bucks monthly & were sitting in the dark like a flipin mushroom!

 

I want to see an NR from both companies, this is total B when ya have to go threw other peoples private calls & messages to try & shed some light on just what the    is going on!

Share
New Message
Please login to post a reply